zanubrutinib

A drug used to treat mantle cell lymphoma in adults who have already received at least one other treatment. It is also being studied in the treatment of other types of cancer. Zanubrutinib blocks a protein called Bruton’s tyrosine kinase (BTK), which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called Brukinsa.